Analyst Recommendations

Oppenheimer analyst issues OUTPERFORM recommendation for PNR on February 4, 2026 01:33PM ET. The previous analyst recommendation was Outperform.PNR was trading at $94.79 at issue of the analyst...

February 4, 2026   PNR -2.20%

Lake Street analyst issues BUY recommendation for TATT on February 4, 2026 01:43PM ET. The previous analyst recommendation was Buy.TATT was trading at $48.72 at issue of the...

February 4, 2026   TATT -9.43%

RBC Capital analyst issues OUTPERFORM recommendation for EPD on February 4, 2026 01:44PM ET. The previous analyst recommendation was Outperform.EPD was trading at $34.63 at issue of the...

February 4, 2026   EPD 0.17%

RBC Capital analyst issues OUTPERFORM recommendation for EMR on February 4, 2026 01:45PM ET. The previous analyst recommendation was Outperform.EMR was trading at $152.1 at issue of the...

February 4, 2026   EMR -1.37%

Cowen & Co. analyst issues BUY recommendation for CPRI on February 4, 2026 01:44PM ET. The previous analyst recommendation was Buy.CPRI was trading at $20.08 at issue of...

February 4, 2026   CPRI -2.78%

Cowen & Co. analyst issues BUY recommendation for MDLZ on February 4, 2026 01:45PM ET. The previous analyst recommendation was Buy.MDLZ was trading at $59.47 at issue of...

February 4, 2026   MDLZ -0.50%

Wolfe Research analyst issues OUTPERFORM recommendation for FN on February 4, 2026 01:46PM ET. The previous analyst recommendation was Peer Perform.FN was trading at $448.53 at issue of...

February 4, 2026   FN -6.76%

Lake Street analyst issues BUY recommendation for CDRE on February 4, 2026 01:50PM ET. The previous analyst recommendation was Buy.CDRE was trading at $42 at issue of the...

February 4, 2026   CDRE -2.21%

Cowen & Co. analyst issues HOLD recommendation for EPD on February 4, 2026 01:51PM ET. The previous analyst recommendation was Hold.EPD was trading at $34.63 at issue of...

February 4, 2026   EPD 0.17%

Cowen & Co. analyst issues BUY recommendation for AMGN on February 4, 2026 01:49PM ET. The previous analyst recommendation was Buy.AMGN was trading at $338.59 at issue of...

February 4, 2026   AMGN -0.61%